Clinical Trial Update: Evaluate the Efficacy and Safety of the Digital Therapeutics Repeech for the Post-Stroke Dysarthria. [NA]

View source ↗

Summary

This clinical trial update announces a new study evaluating the efficacy and safety of the digital therapeutic Repeech for post-stroke dysarthria, which is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Dysarthria

Drugs mentioned

• Repeech

Snippet

Sponsor: HAII corp.ltd | Conditions: Post-stroke Dysarthria | NA | Status: NOT_YET_RECRUITING